Artwork

Το περιεχόμενο παρέχεται από το Jon Chee. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Jon Chee ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Player FM - Εφαρμογή podcast
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !

🧬 Quin Wills - Ochre Bio - Part 4 | Quin’s Journey Through Y Combinator | The Role of Empathy in Team Dynamics | Adapting in a Shifting Biotech Industry | Ochre Bio’s Fundraising Journey & Future Plans

22:26
 
Μοίρασέ το
 

Manage episode 423369312 series 3461709
Το περιεχόμενο παρέχεται από το Jon Chee. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Jon Chee ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.


Part 4 of 4.

My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhosis complications.

In addition to his work at Ochre, Quin is also a highly accomplished academic with a medical degree from Witwatersrand University and doctoral degrees from Cambridge and Oxford in computational biology, mathematics, and statistical genomics.

Along with his academic accomplishments, Quin also co-founded SimuGen and has worked at the University College London, the Mayo Clinic, and Novo Nordisk before he went on to co-found Ochre Bio. Quin's diverse experiences offer a wealth of insights that everyone can draw inspiration from.

Join us this week and hear about Quin’s:

  • Unique journey through Y Combinator and its impact
  • Thoughts about empathy’s role in organizational and team dynamics
  • Strategies for adapting as an entrepreneur in a shifting biotech landscape
  • Experience expanding Ochre Bio globally and the challenges of scaling
  • Fundraising journey and his unconventional tips for aspiring entrepreneurs

Please enjoy my conversation with Quin Wills.
Find Our Guest, Quin Wills, at these links:

Find Our Host, Jon Chee, at these links:
00:28 Intro
01:46 Applying to and joining Y Combinator
03:19 Building a full stack solution for Ochre Bio and generating critical data
05:04 The impact of COVID-19, expanding globally to Taiwan and the US
08:48 Day-to-day operations and scientific structure of Ochre Bio
09:42 Investing in chemistry, establishing XLAB and its role in innovation and decision-making
11:42 Balancing innovation and value-driven projects, defining metrics of success
12:38 Quin’s fundraising journey, insights, and philosophy
13:49 The importance of focus and ending unproductive projects quickly
16:11 Ochre Bio’s evolution and future plans
17:19 Quin’s shoutouts and advice to his 21-year-old self
20:03 Outro

Social & Website
Enriched Notes:
Topics Mentioned:

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

89 επεισόδια

Artwork
iconΜοίρασέ το
 
Manage episode 423369312 series 3461709
Το περιεχόμενο παρέχεται από το Jon Chee. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Jon Chee ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.


Part 4 of 4.

My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhosis complications.

In addition to his work at Ochre, Quin is also a highly accomplished academic with a medical degree from Witwatersrand University and doctoral degrees from Cambridge and Oxford in computational biology, mathematics, and statistical genomics.

Along with his academic accomplishments, Quin also co-founded SimuGen and has worked at the University College London, the Mayo Clinic, and Novo Nordisk before he went on to co-found Ochre Bio. Quin's diverse experiences offer a wealth of insights that everyone can draw inspiration from.

Join us this week and hear about Quin’s:

  • Unique journey through Y Combinator and its impact
  • Thoughts about empathy’s role in organizational and team dynamics
  • Strategies for adapting as an entrepreneur in a shifting biotech landscape
  • Experience expanding Ochre Bio globally and the challenges of scaling
  • Fundraising journey and his unconventional tips for aspiring entrepreneurs

Please enjoy my conversation with Quin Wills.
Find Our Guest, Quin Wills, at these links:

Find Our Host, Jon Chee, at these links:
00:28 Intro
01:46 Applying to and joining Y Combinator
03:19 Building a full stack solution for Ochre Bio and generating critical data
05:04 The impact of COVID-19, expanding globally to Taiwan and the US
08:48 Day-to-day operations and scientific structure of Ochre Bio
09:42 Investing in chemistry, establishing XLAB and its role in innovation and decision-making
11:42 Balancing innovation and value-driven projects, defining metrics of success
12:38 Quin’s fundraising journey, insights, and philosophy
13:49 The importance of focus and ending unproductive projects quickly
16:11 Ochre Bio’s evolution and future plans
17:19 Quin’s shoutouts and advice to his 21-year-old self
20:03 Outro

Social & Website
Enriched Notes:
Topics Mentioned:

People Mentioned:
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

89 επεισόδια

Wszystkie odcinki

×
 
Loading …

Καλώς ήλθατε στο Player FM!

Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.

 

Οδηγός γρήγορης αναφοράς